GlycoMimetics, Apollomics announce collaboration and license agreement for GMI-1687
GlycoMimetics, Apollomics announce exclusive collaboration and license agreement to develop and commercialise Uproleselan and GMI-1687 in Greater China. Credit: Tumisu from Pixabay.